跳至主要内容
临床试验/CTRI/2022/01/039373
CTRI/2022/01/039373尚未招募未知

Safety and efficacy of Lactobacillus GG (ATCC 51303) in children with functional abdominal pain: A randomised double blinded placebo controlledtrial.

Geetanjali Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Children has a Functional Abdominal Pain according to the Rome IV (H2d) diagnostic
  • Must be fulfilled at least 4 times per month and include all of the following:
  • 1. Episodic or continuous abdominal pain that does not occur solely during physiologic events (e.g.,
  • eating, menses)
  • 2. Insufficient criteria for irritable bowel syndrome, functional dyspepsia, or abdominal migraine.
  • 3. After appropriate evaluation, the abdominal pain cannot be fully explained by another medical
  • Criteria fulfilled for at least 2 months before diagnosis.

排除标准

  • 1. History of any other diagnosed chronic diseases,
  • 2. History of use of probiotics in the previous 2 months,
  • 3. History of any previous abdominal surgery.
  • 4. Children whose parents not willing to give consent.

研究者

发起方
Geetanjali Medical College and Hospital

相似试验